Prospective evaluation of the significance of dose adjustment in rituximab plus CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma
Phase 2
Recruiting
- Conditions
- Diffuse large B cell lymphoma
- Registration Number
- JPRN-UMIN000025569
- Lead Sponsor
- Tochigi Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 62
Inclusion Criteria
Not provided
Exclusion Criteria
(1)testis,CNS invasion/IVL,transformation from loe grade lymphoma (2)HIV infection (3)severe infection (4)Psycological disorder like schizophrenia. (5)Active or non-curable synchronous malignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method